These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9677660)

  • 41. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 42. [Epidemiology of meningococcal infection in the province of Seville (1962-1963 to 1981-1982)].
    Blasco Huelva PM; García Serna D
    Rev Sanid Hig Publica (Madr); 1985; 59(3-4):395-416. PubMed ID: 4081604
    [No Abstract]   [Full Text] [Related]  

  • 43. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Vaccine coverage survey per cluster sampling after an antimeningococcal mass vaccination campaign at Niamey, Niger in 2000].
    de Chabalier F; Garba A; Chippaux JP
    Sante; 2001; 11(3):173-6. PubMed ID: 11641081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients].
    de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
    Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R
    Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An unusual transmission event of Neisseria meningitidis serogroup W135 type 2a in a healthcare setting, England, 2012.
    Puleston R; Beck C; Tahir M; Bardhan M; Charlemagne P; Alves C; Ladhani S; Watson C; Ramsay M; Kaczmarksi E; Borrow R; Gray S; Hadlington D; Weinbren M; Bhattacharjee D; Inglis N
    Euro Surveill; 2012 Nov; 17(44):. PubMed ID: 23137486
    [No Abstract]   [Full Text] [Related]  

  • 49. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease.
    Kellerman SE; McCombs K; Ray M; Baughman W; Reeves MW; Popovic T; Rosenstein NE; Farley MM; Blake P; Stephens DS;
    J Infect Dis; 2002 Jul; 186(1):40-8. PubMed ID: 12089660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Annual report of the Australian Meningococcal Surveillance Programme, 1997.
    Commun Dis Intell; 1998 Oct; 22(10):205-11. PubMed ID: 9803595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meningococcal disease in New Zealand: an audit of disease notification and contact management.
    Bandaranayake D
    N Z Med J; 1994 Oct; 107(987):399-402. PubMed ID: 7936479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Communicable diseases report, NSW, for May 2003.
    N S W Public Health Bull; 2003 Jul; 14(7):151-8. PubMed ID: 14562146
    [No Abstract]   [Full Text] [Related]  

  • 53. Current problems in meningococcal disease.
    Wall RA
    J Med Microbiol; 1988 Jul; 26(3):163-5. PubMed ID: 3292768
    [No Abstract]   [Full Text] [Related]  

  • 54. [Adverse urologic effects: impotence, fertility disorders, bladder carcinoma].
    Stackl W
    Wien Med Wochenschr; 1994; 144(22-23):550-1. PubMed ID: 7701838
    [No Abstract]   [Full Text] [Related]  

  • 55. Update on meningococcal disease mortality in the United States since 2002.
    Kim GY; Sorvillo F; Kuo T
    Pediatr Infect Dis J; 2010 Jul; 29(7):681. PubMed ID: 20574406
    [No Abstract]   [Full Text] [Related]  

  • 56. Meningococcal disease: a call for vigilance.
    Moll M; Mainzer H
    Pa Med; 1994 Mar; 97(3):34-5. PubMed ID: 8065766
    [No Abstract]   [Full Text] [Related]  

  • 57. [Meningococcal diseases in Halland. Sulfaprevention is back again].
    Lindberg A; Ripa T
    Lakartidningen; 1983 Nov; 80(46):4410-2. PubMed ID: 6656483
    [No Abstract]   [Full Text] [Related]  

  • 58. Meningococcal infections: sixteen years' experience.
    Saxe TG; Finch RG
    W V Med J; 1978 May; 74(5):99-102. PubMed ID: 274017
    [No Abstract]   [Full Text] [Related]  

  • 59. [Meningococcal infection prevention].
    Rev Infirm; 1990 Oct; 40(16):53-4. PubMed ID: 2244149
    [No Abstract]   [Full Text] [Related]  

  • 60. The detection of meningococcal household clusters and their prophylaxis in the changing epidemiological situation of invasive meningococcal disease in Poland, 2003-2006.
    Stefanoff P; Rosinska M; Karczewski G; Zielinski A
    Euro Surveill; 2008 Mar; 13(10):. PubMed ID: 18445440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.